The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Fatty Acid Binding Receptors and Their Physiological Role in Type 2 Diabetes
Swaminath, G. (2008) · Archiv der Pharmazie · doi:10.1002/ardp.200800096 · Cited by 54
Gautam, D., Jeon, J., Li, J. H., Han, S., Hamdan, F. F., Cui, Y., Lü, H., Deng, C., Gavrilova, O., & Wess, J. (2008) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890801942002 · Cited by 53
The role of G protein-coupled receptor 40 in lipoapoptosis in mouse β-cell line NIT-1
Zhang, Y., Xu, M., Zhang, S., Yan, L., Yang, C., Lu, W., Li, Y., & Cheng, H. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0048 · Cited by 51
Åhrén, B., Sauerberg, P., & Thomsen, C. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e93 · Cited by 49
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
Åhrén, B. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0056-9 · Cited by 48
Ueda, N., Okamoto, Y., & Morishita, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.018 · Cited by 47
Islet b cell failure in type 2 diabetes
Prentki, M., & Nolan, C. J. (2006) · Cited by 47
Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors
Parandeh, F., Abaraviciene, S. M., Amisten, S., Erlinge, D., & Salehi, A. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.119 · Cited by 46
Brownlie, R., Mayers, R. M., Pierce, J. A., Marley, A. E., & Smith, D. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360950 · Cited by 46
Bollheimer, L. C., Landauer, H. C., Troll, S., Schweimer, J., Wrede, C. E., Schölmerich, J., & Buettner, R. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.011 · Cited by 45
Schmitz, O., Russell-Jones, D. L., Vaag, A. A., Sethi, B. K., Lalic, N. M., Antić, S., Zdravkovic, M., Ravn, G. M., & Simó, R. (2008) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(08)24116-x · Cited by 45
The Free Fatty Acid Receptor GPR40 Generates Excitement in Pancreatic β-Cells
Gromada, J. (2006) · Endocrinology · doi:10.1210/en.2005-1388 · Cited by 42
Is GPR39 the natural receptor of obestatin?
Dong, X., He, J.-M., Tang, S.-Q., et al. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.022 · Cited by 41
Bartoov-Shifman, R., Ridner, G., Halpern, K. B., Rubins, N. E., & WALKER, M. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702115200 · Cited by 41
Human glucagon receptor antagonists based on alkylidene hydrazides
Ling, A. L., Plewe, M. B., González, J., Madsen, P., Sams, C. K., Lau, J. F., Gregor, V. E., Murphy, D., Teston, K., Kuki, A., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00819-8 · Cited by 40
G Protein-Coupled Receptors and Insulin Secretion: 119 and Counting
Madiraju, S. R. M., & Poitout, V. (2007) · Endocrinology · doi:10.1210/en.2007-0336 · Cited by 40
Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists
Bharate, S. B., Rodge, A. H., Joshi, R. K., Kaur, J., Srinivasan, S., Kumar, S., Kulkarni‐Almeida, A., Balachandran, S., Balakrishnan, A., & Vishwakarma, R. A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.085 · Cited by 39
Deacon, C. F. (2008) · PubMed · Cited by 37
Potentiated β-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice
Simonsson, E., & Åhrén, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00236-2 · Cited by 31
High Throughput Screening for Orphan and Liganded GPCRs
Xiao, S.-H., Reagan, J. D., Lee, P., Fu, A., Schwandner, R., Zhao, X., Knop, J., Beckmann, H., & Young, S. W. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708783877762 · Cited by 31
Analysis of gene expression in pancreatic islets from diet-induced obese mice
Imai, Y., Patel, H. R., Doliba, N. M., Matschinsky, F. M., Tobias, J. W., & Ahima, R. S. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00050.2008 · Cited by 31
Campbell, R. K., & White, J. R. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708317870 · Cited by 31
Zhao, Y.-F., Pei, J., & Chen, C. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0105 · Cited by 30
Younan, S. M., & Rashed, L. A. (2007) · PubMed · Cited by 28
Exenatide: a novel treatment of Type 2 diabetes
Åhrén, B. (2005) · Therapy · doi:10.2217/14750708.2.2.207 · Cited by 26
Chevassus, H., Roig, A., Belloc, C., Lajoix, A., Broca, C., Manteghetti, M., & Petit, P. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0620-4 · Cited by 26
Lugo‐Garcia, L., Filhol, R., Lajoix, A., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.012 · Cited by 24
Effects of acute α2-blockade on insulin action and secretion in humans
Natali, A., Gastaldelli, A., Galvan, A. Q., Sironi, A. M., Ciociaro, D., Sanna, G., Rosenzweig, P., & Ferrannini, E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.1.e57 · Cited by 21
Skoglund, G., Gross, R., Åhrén, B., & Loubatières-Mariani, M.-M. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90228-a · Cited by 19
Established Therapies for Diabetes Mellitus
Hsia, S. H., & Davidson, M. B. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000192 · Cited by 14
Preclinical pharmacology of the new GLP-1 receptor agonist AVE0010
Werner, U. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.02.022 · Cited by 14
Emerging Therapies for Type 2 Diabetes
Stonehouse, A. H., & Maggs, D. G. (2007) · Current Drug Therapy · doi:10.2174/157488507780619103 · Cited by 8
Vildagliptin: novel pharmacological approach to treat Type 2 diabetes
Åhrén, B. (2008) · Therapy · doi:10.2217/14750708.5.1.79 · Cited by 6
(2002) · doi:10.1002/1439-7633(20021004)3:10<928::aid-cbic928>3.0.co;2-5
Cited by
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
Albumin as a versatile platform for drug half-life extension
Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 485
A chemical-genetic approach to study G protein regulation of β cell function in vivo
Guettier, J.-M., Gautam, D., Scarselli, M., de Azua, I. R., Li, J. H., Rosemond, E., Ma, X., Gonzalez, F. J., Armbruster, B. N., Lu, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906593106 · Cited by 344
Metadata
- Authors
- Ahrén, B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-04-14
- Volume
- 8
- Issue
- 5
- Pages
- 369-385
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2094177994
- Cited by
- 419
- References
- 234
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.